Pharmaceuticals Market Research Reports & Industry Analysis

... quotation of cholesterol and vitamin D3 (VD3). Garden Biochemical, one of the largest manufacturers of VD3 in the world, the supply of VD3 was in short, ... and project basic information, suggestion or prospect analysis. What to report: In this report, some of the most relevant domestic vitamin projects have ...

... in various ways. In this report, development situation of vitamin listed companies has been described in detail, including company profile, financial performance, product mix, market share ...

... ’s overall healthcare services and facilities. In our latest research study “Brazil Pharmaceutical Market Outlook 2018”, RNCOS’ analysts have identified the ... , which stood at US$ 26.89 Billion in 2013, is expected to grow at a CAGR of 14.5% during 2013-2018. RNCOS’ analysis shows that the Over-the-Counter drug ...

... also Physician Views: What opportunity for biosimilar basal insulin?), we are polling US and EU5-based endocrinologists to gauge their assessment of new long-acting insulins ... Lantus sales will be flat next year (due most likely to greater rebating with payers) and the potential leverage their availability will ...

... main drivers to galvanized Influenza vaccines market. Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow ... digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and ...

... Non Hodgkin Lymphoma therapeutics. “Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight” Report Highlight: Global Non Hodgkin Lymphoma Market Overview Mechanism of Non Hodgkin Lymphoma Therapeutics Global Non Hodgkin Lymphoma Pipeline by Type, Phase & Company Global Non Hodgkin Lymphoma Pipeline ...

... more about the conditions of China’s pharmaceutical industry; Report topics: Relevant government regulations Key suppliers Mergers & acquisitions cases Technology R&D Drug pricing reform Pharmacy trusteeship Industry forecast: China’s pharmaceutical industry has developed rapidly during ...

Competitor Analysis: Ebola Virus Vaccines and Therapeutics The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections ... Ebola virus infections as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... a direct analyse of China's vitamin trade flows around the volume, price, partners, and an indirect description of industry changes. What to report: In this report, import and export of China's vitamins in 2013 and ...

... Hepatitis C Pipeline Drugs - Clinical Trials The report gives an insight on the Hepatitis C Deals and Acquisitions (2004 - 2014) iGATE RESEARCH report entitled Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019 provides an in-depth analysis of the drugs, pipeline drugs and the key players ...

... drugs would meet orphan drug criteria. Orphan Drugs are part of the clinical landscape and all stakeholders have valid interests which have to be addressed now. Orphan Drug Market Access: Payer Insights on the Present and Future offers insights from US and European healthcare payers and includes illustrative case ...

... whom subsequently need the anticoagulant action to be reversed due to bleeding or the requirement for surgery. Portola's assertion that andexanet alfa will meet ... who compete in this segment. Portola's recently unveiled Phase III data demonstrates the ability of andexanet alfa to reverse the effect of Eliquis, but ...

Patient assistance programs (PAPs) are evolving in response to increasingly restrictive formularies and payer criticism. Patient Assistance Programs: Payer and Pharma Perspectives is a report that gives unique insight into payer ... and coupon models, payers have been increasingly resistant and critical of the new PAP schemes. FirstWord’s Patient Assistance Programs: Payer and Pharma Perspectives report ...

... Ebola Virus Vaccine Market & Pipeline Insight” Report Highlight: Ebola Virus Infection Market Overview Ebola Vaccine Clinical Trial Insight by Phase, Company & Country Ebola Vaccine in Clinical Trials: 26 Vaccine Majority Ebola Vaccine in Preclinical Phase: 15 Vaccines Ebola Vaccines ...

... Cancer Monoclonal Antibodies Pipeline by Phase, Indication, Company & Country Cancer Monoclonal Antibodies in Pipeline: 605 Majority Cancer Monoclonal Antibodies Preclinical Phase: 258 Marketed Cancer Monoclonal Antibodies: 34 Cancer Monoclonal Antibodies ...

... Global Cancer Kinase Inhibitors Market & Pipeline Insight” Report Highlight: Classification & Mechanism of Kinase Inhibitors Cancer Kinase Inhibitors Therapy Market Overview Cancer Kinase Inhibitors Therapy Pipeline by Phase, Indication, Company & Country Marketed Cancer Kinase Inhibitors Therapy ...

... Gene Therapy to Cancer Treatment Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook FDA & AMA Guidelines for Gene Therapy Gene Therapy Pipeline by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline ...

Competitor Analysis: Rabies Virus Vaccines, Antibodies and Immune Globulins The present Competitive Intelligence Report about prophylaxis and therapy of Rabies ... virus infections as of September 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...

... days after order is placed. Netscribes’ latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and ... promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive ...

... Cancer Vaccines Delivery Cancer Vaccines: Mechanism & Innovations Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country Global Cancer Vaccine Clinical Pipeline: 289 Vaccines Marketed Cancer Vaccines: 12 Vaccines Regulatory Framework for Cancer Vaccines Development & Marketing ...

... . “Recombinant Therapeutic Proteins Market & Pipeline Analysis” Report Highlights: Global Market Overview Mechanisms of Recombinant Protein Production Types of Recombinant DNA Technology Clinical Pipeline by Phase, Indication, Company, & Country Marketed Recombinant Therapeutic Protein Drugs ...

... Pharmaceuticals products sales in Saudi Arabia are expected to surpass US$ 7 Billion by 2018 as compare to US$ 4.40 Billion 2013. “Saudi Arabia Pharmaceutical Market Development Analysis” Report Highlight: Market Overview Drug Pricing system Disease Prevalence Market ...

... disorders, which are extremely life-threatening. As per the official definition, rare diseases are classified as those that affect fewer than 200, ... & FDA Regulatory Framework US Orphan Drug Pipeline by Phase, Indication & Company Marketed Orphan Drug Clinical Insight US Orphan Drug Clinical Pipeline: 570 ...

... purchasing Hard Copy License depending on the location. The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry ... with launch of novel drugs will drive the growth of CNS disease market in future. “US CNS Disorders Drug Pipeline Insight 2014” Report ...

... Global HIV Infection Drug Market & Pipeline Insight” Report Highlight: Global HIV Infection Drug Market Overview & Incidence Scenario FDA & EMA Regulation for Development of HIV Drug Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country Global HIV Clinical Pipeline: 315 Drugs ...

... segmented the CIS Insulin market on the basis of product, application, source and region: CIS Insulin Product Outlook Rapid Acting Long Acting Premixed Premixed Analog Short Acting Intermediate Acting CIS Insulin Application ...

... use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: Cancer Immunotherapy Market Overview Cancer Immunotherapy Market Dynamics Cancer Immunotherapy Pipeline: 1080 Drug in Clinical Pipeline Cancer Monoclonal Antibodies Clinical Pipeline by Phase & Country Cancer Vaccine Clinical ...

... (PPV) and other varieties. Since 2011, the bids for compulsory vaccines proposed by the Chinese government has turned to be more fierce, with ... Group, Tecon and Dahuanong with a combined proportion of 15% or so. China Animal Vaccine Industry Report, 2013-2016 by ResearchInChina covers the followings: The ...

... could thus be used as a basis of the vaccine. There are only 2 HPV vaccines which are currently marketed across the globe. Both ... to treat it, either through drugs or through vaccines. “Human Papillomavirus Infections Vaccine Pipeline Analysis” Report Highlights: Human Papillomavirus Vaccine Market Overview ...

... are also being analyzed. A majority of these studies were previously focusing on cervical cells in women. But in recent years, the realm of research has ... lead to the growth of abnormal cells, thus controlling the incidence of cervical cancer. “Cervical Cancer Drug Market & Pipeline Insight” Report Highlights ...

... offers much potential for future prevention and cure over the next two decades. “Schizophrenia Drug Market & Pipeline Insight” Report Highlights: Schizophrenia Drug Market Overview Marketed Drug Profiles & Patent Analysis Clinical Trial Insight by Phase & Country Drug in Clinical Development Phase: ...

... in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR ... Outlook Human Recombinant Analogs Insulin Regional Outlook Brazil Argentina Chile Mexico Colombia Venezuela Peru Rest of Latin America

... the spread of cancer. “Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Cancer Cell Therapy Market Overview Cancer Cell Therapy Market Dynamics Clinical Pipeline by Phase, country & Target Indications Cancer Cell Therapy Drugs in Pipeline: 82 Highest Number of Drugs in Preclinical ...

... titled “Global Anti-Migraine Drugs Market: Trends and Opportunities (2014-2019)” provides an insight into migraine drugs with a special focus on Triptans. The report also includes the market value ... generic migraine drugs over the next several years will steadily increase diagnosis and drug-treatment rates, leading to sustained annual global growth of anti-migraine drugs market. Other ...

... the function and regulation of iron.The key factors driving growth of the global IV iron industry include escalating number of dialysis ... report analyzes the global iron products industry along with an extensive coverage of global and the US IV iron market. The global IV iron market witnesses intense ...

... top two consumers of feed water-soluble vitamins and minerals in the world, having collectively accounted for more than 61% and 53% of the consumption of feed water-soluble minerals and feed water-soluble vitamins, respectively, in 2012. Asia-Pacific is estimated to be the fastest-growing market for feed water-soluble minerals, in terms of value. Growth is particularly ...

... the diagnostic techniques as the researchers would get a deeper understanding of the disease. Thus, overall, there is significant amount of research currently underway for ... , it is most likely that this market would offer better solutions for the patients. “Crohn’s Disease Drug Market and Pipeline Analysis” ...

... as a result of continued initiatives to improve healthcare access. The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key ... Insulin Regional Outlook India China Australia New Zealand South Korea Taiwan Philippines Vietnam Indonesia Japan Malaysia Thailand Rest of Asia Pacific

... and market value in the years to come. The Antibody Drug Conjugates market will definitely witness an increase in the partnership and collaborative agreements to develop these drugs. It has ... source of knowledge. “Antibody Drug Conjugate Market Opportunity Analysis” Report Highlights: Global ADC Market Insight ADC Patent Analysis Orphan Status & ADC Favorable Market Drivers & Key Issues ...

... activities and generic competition for off patent products. On the contrary, vaccine segment has developed as highly profitable because of advancements in genomics and ... sales, which thereby allure the market players. The report, “Global Vaccine Market Outlook 2020” provides an extensive research and in-depth ...

... National Accord Medicines still firmly held the first place in China's top 100 pharmaceutical chain enterprises, with the sales value for ... , to a certain extent, restrict the development of Chinese pharmaceutical B2C market. China Pharmaceutical Distribution Industry Report, 2013-2017 involves the following: ...

... trials gain knowledge about the latest medical advances. “Singapore Clinical Trial Market Analysis” research report by KuicK Research is an intriguing text that gives detailed facts and analysis on latest developments in the Singapore Clinical Trial Market. Report discusses ...

... insulin products by exhibiting higher efficacy. North America was the largest regional market ... insulin market on the basis of product, segment (on the basis of source), application and region: Insulin Product Outlook Fast Acting Insulin Short Acting Insulin Intermediate Acting Insulin Long Acting Insulin ...

... is forecasted to grow at a CAGR of over 10% during 2012-2018. Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the ... comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars. The report conducts an ...

... drugs crowding the market, it is expected that this market would grow at a CAGR of 8% to reach close to US$ 17.5 billion by 2018. “COPD Drug Market Opportunity & Clinical Pipeline Analysis” Report Highlight: COPD Drug Market Overview COPD Patient Base: Global, US & Europe FDA & EMA Guidelines on Clinical Investigation of COPD Drugs COPD Drug Clinical Pipeline ...

... “Global Influenza (Flu) Vaccine Market: Trends and Opportunities (2014-2019)” provides an insight into the market dynamics and various trends and opportunities associated with the global Influenza vaccine market. It covers the global market size and growth dynamics of the influenza vaccine market in past ...

... lines), microorganism-based and others. Of the 140 clinical stage cancer vaccines, three were approved and are commercialized in the major ... . In addition, the report lists company-specific R&D pipelines of cancer vaccines. Competitor projects are listed in a tabular format providing information on: Drug ...

... Produced by Different Enterprises in China Hospital Market Sales Value of Valsartan Hydrochlorothiazide in China Hospital Market Major Valsartan Hydrochlorothiazide Manufacturers in China Prospect of China Valsartan Hydrochlorothiazide Market The following enterprises and people are recommended to ...

... of Adalimumab in Hospital Market in China Price of Adalimumab Produced by Vetter Pharma Fertigung GmbH & Co. KG in China Hospital, 2014 Manufacturing Schedule of Adalimumab Generic Drug Prospect of China Adalimumab Market The following enterprises and people are recommended to purchase this report: ...

... China. According to CRI's market investigation, the sales revenue of Lyrica in Chinese sample hospital market grew over 100 times from 2010 to 2013. ... incidence of epilepsy is doomed to increase, which leads to a bright future for pregabalin market in China. Through this report, the readers can acquire the ...